Publications by authors named "Arnaud Bourreille"

67Publications

Small bowel capsule endoscopy and treat-to-target in Crohn's disease: A systematic review.

World J Gastroenterol 2019 Aug;25(31):4534-4554

Institut des Maladies de l'Appareil Digestif, Nantes University Hospital, Nantes 44093, France,

View Article and Find Full Text PDF
August 2019

Crohn's-like acute severe colitis associated with Hermansky-Pudlak syndrome: A case report.

World J Gastroenterol 2019 Feb;25(8):1031-1036

Institut des Maladies de l'Appareil Digestif, Department of Gastroenterology and Digestive Oncology, Nantes University Hospital, Nantes Cedex 44093, France.

View Article and Find Full Text PDF
February 2019

Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases.

Gastrointest Endosc 2019 03 16;89(3):626-636. Epub 2018 Aug 16.

Université de Nantes, INSERM, IMAD, The Enteric Nervous System in Gut and Brain Disorders, Université Bretagne Loire, Nantes, France; Institut des Maladies de l'Appareil Digestif, IMAD, CHU Nantes, Hopital Hôtel-Dieu, Nantes, France.

View Article and Find Full Text PDF
March 2019

An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8 T cells involved in multiple sclerosis.

J Autoimmun 2018 03 18;88:61-74. Epub 2017 Oct 18.

Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France; Faculté de Médecine, Université de Nantes, Nantes, France; Service de Neurologie, CHU Nantes, Nantes, France; INSERM 015, Centre d'Investigation Clinique, Nantes, France. Electronic address:

View Article and Find Full Text PDF
March 2018

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.

Inflamm Bowel Dis 2017 03;23(3):333-340

1Institute of Translational Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom; 2Department of Gastroenterology, University Hospital CHU of Liège, Liège, Belgium; 3Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine, ERL 1057 INSERM/UMRS 7203, and GRC-UPMC 03, UPMC Univ, Paris, France; 4Department of Gastroenterology, Imelda Gastrointestinal Clinical Research Centre, Imelda General Hospital, Bonheiden, Belgium; 5CHU Pontchaillou Rennes & Université de Rennes 1, Service des Maladies de l'Appareil Digestif, Rennes, France; 6CHU Nantes, Institut des Maladies de l'Appareil Digestif, Université de Nantes, Nantes, France; 7Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium; 8Département Gastroenterologie, Hôpital Erasme, Université libre de Bruxelles, Bruxelles, Belgium; 9Department of Gastroenterology, Hepatology and Clinical Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada; 10Centre Hospitalier Universitaire de Nice, Service de Gastroentérologie et Nutrition Clinique, Nice, France; 11Université de Nice-Sophia-Antipolis, Faculté de Médecine, Nice, France; 12Department of Medicine (Division of Gastroenterology), Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada; 13AbbVie Inc, Dublin, Ireland; 14Division of Gastroenterology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; 15Division of Digestive Care and Endoscopy, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; and 16Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.

View Article and Find Full Text PDF
March 2017

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

Inflamm Bowel Dis 2016 12;22(12):2924-2932

1Service de Gastroentérologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France; 2Université Claude Bernard Lyon 1, Lyon, France; 3Service de Gastroentérologie, Hôpital Lariboisière, AP-HP, Paris, France; 4Service de Gastroentérologie, American University of Beirut Medical Center, Beirut, Lebanon; 5Service de Gastroentérologie, Hôpital Claude Huriez, Lille, France; 6Service de Gastroentérologie, Hôpital Charles Nicolle, Rouen, France; 7Service de Gastroentérologie, Hôpital Haute-Pierre, Strasbourg, France; 8Institut des Maladies de l'Appareil Digestif, CHU de Nantes, CIC Inserm 1413, Université de Nantes, Nantes, France; 9Service de Gastroentérologie, Hôpital Robert Debré, Reims, France; 10Service de Gastroentérologie, CHU d'Amiens, Amiens, France; 11Service de Gastroentérologie, Hôpital de Rangueil, Toulouse, France; 12Service d'Hépatologie, AP-HP, Hôpital Saint-Antoine, Paris, France; 13Service de Gastroentérologie, Hôpital Beaujon, AP-HP, Clichy, France; 14Department of Gastroenterology, University Hospital of Liège, Liège, Belgium; and 15Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du tube Digestif, Service de Gastroentérologie, AP-HP, Hôpital Saint-Louis, Paris, France.

View Article and Find Full Text PDF
December 2016

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.

Inflamm Bowel Dis 2016 06;22(6):1362-9

1CHU de Bordeaux, Hôpital Haut-Le[Combining Acute Accent]vêque, Service d'He[Combining Acute Accent]pato-gastroente[Combining Acute Accent]rologie, University of Bordeaux, Bordeaux, Pessac, France; 2Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine, ERL 1157 INSERM/UMRS 7203, DHU 12B, UPMC, Paris, France; 3Department of Gastroenterology, Henri Mondor Hospital, Assistance Publique Hôpitaux de Paris, Paris Est Creteil University, Paris, France; 4CHRU de Lille, Hôpital Claude Huriez, Service des Maladies de l'Appareil Digestif-Endoscopie Digestive, Lille, France; 5Department of Gastroenterology, Cochin Hospital, Assistance Publique Hôpitaux de Paris and Paris V University, Paris, France; 6Hôpital Beaujon, Gastroente[Combining Acute Accent]rologie, Maladies Inflammatoires Chroniques de l'Intestin et Assistance Nutritive, AP-HP, Universite[Combining Acute Accent] Paris VII, Clichy, France; 7Department of Gastroenterology, CHU of Liège, University of Liège, Belgium; 8GIGA Research, University of Liege, Belgium; 9Service d'He[Combining Acute Accent]pato-Gastroente[Combining Acute Accent]rologie, CHU Amiens, Université de Picardie Jules Verne, Amiens, France; 10Department of Gastroenterology, Bichat Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; 11Department of Gastroenterology, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre Benite, France; 12INSERM U1111, CIRI, Lyon, France; 13INSERM U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Université Henri Poincaré 1, Vandoeuvre-lès-Nancy, France; 14Inserm CIC 1114 and Institut des Maladies de l'Appareil Digestif, University Hospital, Nantes, France; 15CHU de Nice, Hôpital de l'Archet 2, Service de Gastroente[Combining Acute Accent]rologie et Nutrition Clinique, Nice, France; 16Department of Hepato-Gastroenterology and Digestive Oncology Hôpital Robert Debré, Reims, France; 17CHU de Rouen, Hôpital Charles Nicolle, Service de Gastroente[Combining Acute A

View Article and Find Full Text PDF
June 2016

Intestinal inflammation and pain management.

Curr Opin Pharmacol 2015 Dec 26;25:50-5. Epub 2015 Nov 26.

INSERM, U1043, Toulouse F-31300, France; CNRS, U5282, Toulouse F-31300, France; Université de Toulouse, UPS, Toulouse F-31300, France. Electronic address:

View Article and Find Full Text PDF
December 2015

Improvement of Refractory Ulcerative Proctitis With Sacral Nerve Stimulation.

J Clin Gastroenterol 2015 Nov-Dec;49(10):853-7

*INSERM UMR 913, Institut des maladies de l'appareil digestif, CHU de Nantes, Université de Nantes †Laboratoire d'anatomie pathologique, CHU de Nantes, Nantes, France.

View Article and Find Full Text PDF
July 2016

Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.

Inflamm Bowel Dis 2015 May;21(5):1047-53

*Department of Hepato-Gastroenterology, University Hospital of Rennes, Pontchaillou and Inserm U991 University of Rennes 1, Rennes, France; †Department of Hepato-Gastroenterology, University Hospital of Bordeaux, Hôpital Haut-Lévêque, Bordeaux, France; ‡Department of Hepato-Gastroenterology, University Hospital Lyon-Sud, University Claude Bernard Lyon 1, Lyon, France; §Department of Gastroenterology and Clinical Nutrition, University Hospital of Nice, University of Nice Sophia Antipolis, Nice, France; ‖Department of Hepato-Gastroenterology, University Hospital of Saint-Etienne, Saint-Etienne, France; ¶Institut des Maladies de l'appareil Digestif (IMAD), University Hospital of Nantes, Nantes, France; and **Inserm, U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Université de Lorraine, Vandoeuvre-les-Nancy, France.

View Article and Find Full Text PDF
May 2015

Endogenous regulation of inflammatory pain by T-cell-derived opioids: when friend turns to foe.

Inflamm Bowel Dis 2014 Oct;20(10):1870-7

*INSERM, Unit 1043, Toulouse, France; †CNRS, Unit 5282, Toulouse, France; ‡Centre de Physiopathologie de Toulouse Purpan, Université de Toulouse, UPS, Toulouse, France; §INSERM, Unit 913, Nantes, France; and ‖Institut des Maladies de l'Appareil Digestif, Université de Nantes, Nantes, France.

View Article and Find Full Text PDF
October 2014

Saccharomyces boulardii does not prevent relapse of Crohn's disease.

Clin Gastroenterol Hepatol 2013 Aug 1;11(8):982-7. Epub 2013 Mar 1.

Institut des Maladies de l'Appareil Digestif (IMAD), Gastroenterology Department, CIC, Inserm-04, CHU, University Hospital, Nantes, France.

View Article and Find Full Text PDF
August 2013

Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12,14-prostaglandin J2.

J Physiol 2010 Jul 17;588(Pt 14):2533-44. Epub 2010 May 17.

INSERM U913 and Institut des Maladies de l'Appareil Digestif, 1, place Alexis Ricordeau, 44093 Nantes Cedex 01, France.

View Article and Find Full Text PDF
July 2010

Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.

Inflamm Bowel Dis 2010 Apr;16(4):684-95

UMR 1280 Physiologie des Adaptations Nutritionnelles, INRA, Université de Nantes, CHU Nantes, Nantes, France.

View Article and Find Full Text PDF
April 2010

[Not Available].

Gastroenterol Clin Biol 2007 Sep;31(8-9P2):27-33

Chirurgien, Hôpital Beaujon, Clichy.

View Article and Find Full Text PDF
September 2007

[Not Available].

Gastroenterol Clin Biol 2007 Sep 30;31(8-9P2):21-6. Epub 2007 Oct 30.

Gastro-entérologue, Paris.

View Article and Find Full Text PDF
September 2007

Enteric glia regulate intestinal barrier function and inflammation via release of S-nitrosoglutathione.

Gastroenterology 2007 Apr 1;132(4):1344-58. Epub 2007 Feb 1.

Division of Gastroenterology, The University of Texas Medical Branch, Galveston, Texas, USA.

View Article and Find Full Text PDF
April 2007

[From corticosteroids to anti-TNF treatments, when dependence takes over].

Gastroenterol Clin Biol 2004 Aug-Sep;28(8-9):696-8

Gastroentérologie et Hépatologie, CHU Nantes.

View Article and Find Full Text PDF
March 2005

Glutamine metabolism in Crohn's disease: a stable isotope study.

Clin Nutr 2004 Oct;23(5):1167-75

INSERM U.539, Human Nutrition Research Center, Hôtel-Dieu Hospital, 2ème étage aile nord, 44093 Nantes Cedex 1, France.

View Article and Find Full Text PDF
October 2004

[Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].

Gastroenterol Clin Biol 2003 Mar;27(3 Suppl):S81-6

Service des Maladies de l'Appareil Digestif et de la Nutrition, Hôpital Huriez, CHU Lille et Equipe INSERM 0114 sur la physiopathologie des maladies inflammatoires intestinales.

View Article and Find Full Text PDF
March 2003